Clinical Trial Update: Study of the SilverHawk™ /TurboHawk™ Plaque Excision Systems Used With SpiderFX to Treat Calcified Peripheral Arterial Disease (DEFINITIVE Ca++) [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports the completion and posting of results for a Phase 2/3 study evaluating the SilverHawk/TurboHawk plaque excision systems used …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Snippet

Sponsor: Medtronic Endovascular | Conditions: Peripheral Arterial Disease | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2014-07-04